FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals ATENOLOL Tablets Recall

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b…

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Mar 29, 2017
Recall ID
D-0605-2017
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled ATENOLOL Tablets starting Mar 6, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0605-2017 on Mar 29, 2017. Reason: Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Product description

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Lot numbers, UPCs & expiration codes

Lot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18

Where it was sold

Nationwide in the USA and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0605-2017
Classification
Class II
Status
Terminated
Recall initiated
Mar 6, 2017
FDA report date
Mar 29, 2017
Quantity
9561 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-0605-2017, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
76673
Address
73 Route 31 N
Code information
Lot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18
Postal code
08534-3601
Report date
Mar 29, 2017
Product type
Drugs
Recall number
D-0605-2017
Classification
Class II
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
9561 bottles
Termination date
Nov 5, 2019
Reason for recall
Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Recall initiation date
Mar 6, 2017
Initial firm notification
Letter
Center classification date
Mar 21, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0605-2017, published Mar 29, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls